pyroglutamyl-histidyl-glycine has been researched along with glucagon-like peptide 1 in 1 studies
| Studies (pyroglutamyl-histidyl-glycine) | Trials (pyroglutamyl-histidyl-glycine) | Recent Studies (post-2010) (pyroglutamyl-histidyl-glycine) | Studies (glucagon-like peptide 1) | Trials (glucagon-like peptide 1) | Recent Studies (post-2010) (glucagon-like peptide 1) |
|---|---|---|---|---|---|
| 42 | 0 | 7 | 9,484 | 1,208 | 6,374 |
| Protein | Taxonomy | pyroglutamyl-histidyl-glycine (IC50) | glucagon-like peptide 1 (IC50) |
|---|---|---|---|
| Glucagon-like peptide 1 receptor | Homo sapiens (human) | 0.0051 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Halmos, T; Suba, I | 1 |
1 review(s) available for pyroglutamyl-histidyl-glycine and glucagon-like peptide 1
| Article | Year |
|---|---|
[Role of the brain in the regulation of metabolism and energy expenditure: the central role of insulin, and insulin resistance of the brain].
Topics: Animals; Appetite Depressants; Appetite Regulation; Blood Glucose; Brain; Ceramides; Cognition; Diabetes Mellitus, Type 2; Energy Metabolism; Fatty Liver; Glucagon-Like Peptide 1; Humans; Hypothalamus; Incretins; Insulin; Insulin Resistance; Intracellular Signaling Peptides and Proteins; Metabolic Syndrome; Neuropeptides; Non-alcoholic Fatty Liver Disease; Oligopeptides; Orexins; Pyrrolidonecarboxylic Acid | 2011 |